Loading…
Reported covered position: Deputy Assistant Secretary for Legislation, Department of Health and Human Services; Senate Finance Health Subcommittee Staff Director, Legislative Assistant, Legislative Aide, Deputy Scheduler, Staff Assistant, Senator Debbie Stabenow.
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: REGENTS OF THE UNIVERSITY OF MICHIGAN · Firm: ALSTON & BIRD LLP
Federal health program issues impacting hospitals. Issues related to H.R.1, One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: REGENTS OF THE UNIVERSITY OF MICHIGAN · Firm: ALSTON & BIRD LLP
Federal health program issues impacting hospitals. Issues related to H.R.1, One Big Beautiful Bill Act.
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
UNITED STATES OLYMPIC & PARALYMPIC COMMITTEE via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues related to Olympic womens and mens collegiate sports. S.4668/H.R.9137, The Protect College Sports Act of 2026.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, State, Dept of (DOS), White House Office
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Source: Senate LDA
| HEALTHTRACKRX |
| 7 |
| 2025–2026 |
| HOSPITAL ASSOCIATION OF OREGON | 7 | 2025–2026 |
| MASSACHUSETTS HOSPITAL ASSOCIATION | 7 | 2025–2026 |
| OREGON HEALTH & SCIENCE UNIVERSITY | 7 | 2025–2026 |
| AFLAC INC | 6 | 2025–2026 |
| CVS HEALTH | 6 | 2025–2026 |
| NATIONAL BRAIN TUMOR SOCIETY | 6 | 2025–2026 |
| THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH | 6 | 2025–2026 |
| NATIONAL ORGANIZATION OF SOCIAL SECURITY CLAIMANTS REPRESENTATIVES (NOSSCR) | 5 | 2025–2026 |
| OSSIUM HEALTH, INC. | 5 | 2025–2026 |
| PROSPEROUS ROBOTICS | 5 | 2025–2026 |
| REGENTS OF THE UNIVERSITY OF MICHIGAN | 5 | 2025–2026 |
| ROSS INNOVATIVE EMPLOYMENT SOLUTIONS CORPORATION | 5 | 2025–2026 |
| AMPUTEE COALITION | 4 | 2026 |
| CLARITEV | 4 | 2025–2026 |
| HEALTH CENTER PARTNERS OF SOUTHERN CALIFORNIA | 4 | 2025–2026 |
| UNITED STATES OLYMPIC & PARALYMPIC COMMITTEE | 4 | 2026 |
| NATIONAL SOCIETY OF AUTISM PROFESSIONALS | 3 | 2026 |
| SCHOOL-COMMUNITY HEALTH ALLIANCE OF MICHIGAN | 3 | 2026 |
| THE METROHEALTH SYSTEM | 3 | 2026 |
| ACCENTURE FEDERAL SERVICES LLC | 2 | 2026 |
| CURIE BIO OPERATIONS, LLC | 2 | 2026 |
| DANA-FARBER CANCER INSTITUTE | 2 | 2025 |
| FAIRVIEW HEALTH SERVICES | 2 | 2025 |
| HOLOGIC, INC. | 2 | 2025 |
| ACT FOR NIH: ADVANCING CURES TODAY | 1 | 2026 |
| AGENDIA, INC. | 1 | 2026 |
| JUDI HEALTH | 1 | 2026 |
Ensuring Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Ensuring Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Support for protecting front line multimission hospitals. Sustainability of safety net health systems. Support of telehealth policies, including for audio-only telehealth services. Support for policies to enhance health care workforce programs. Expanding the healthcare workforce. Support for policies to protect access to Medicaid. Protecting the 340B drug discount program. 340b price transparency issues concerning 340B program rebate proposal. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Trauma center certification, funding, and quality; Market saturation of trauma care and detrimental impact patient outcomes.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Support for protecting front line multimission hospitals. Sustainability of safety net health systems. Support of telehealth policies, including for audio-only telehealth services. Support for policies to enhance health care workforce programs. Expanding the healthcare workforce. Support for policies to protect access to Medicaid. Protecting the 340B drug discount program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Trauma center certification, funding, and quality; Market saturation of trauma care and detrimental impact patient outcomes.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Support for protecting front line multimission hospitals. Sustainability of safety net health systems. Support of telehealth policies, including for audio-only telehealth services. Support for policies to enhance health care workforce programs. Expanding the healthcare workforce. Support for policies to protect access to Medicaid. Protecting the 340B drug discount program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Trauma center certification, funding, and quality; Market saturation of trauma care and detrimental impact patient outcomes.
Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Continuing Appropriations, Agriculture, Legislative Branch, Military Construction and Veterans Affairs, and Extensions Act, 2026
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Medicare Patient Access and Practice Stabilization Act of 2025
Client: THE METROHEALTH SYSTEM · Firm: ALSTON & BIRD LLP
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
Protect College Sports Act of 2026
Client: UNITED STATES OLYMPIC & PARALYMPIC COMMITTEE · Firm: ALSTON & BIRD LLP
Issues related to Olympic womens and mens collegiate sports. S.4668/H.R.9137, The Protect College Sports Act of 2026.
Protect College Sports Act of 2026
Client: UNITED STATES OLYMPIC & PARALYMPIC COMMITTEE · Firm: ALSTON & BIRD LLP
Issues related to Olympic womens and mens collegiate sports. S.4668/H.R.9137, The Protect College Sports Act of 2026.
Equitable Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Equitable Community Access to Pharmacist Services Act
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Protect College Sports Act of 2026
Client: UNITED STATES OLYMPIC & PARALYMPIC COMMITTEE · Firm: ALSTON & BIRD LLP
Issues related to Olympic womens and mens collegiate sports. S.4668/H.R.9137, The Protect College Sports Act of 2026.
Protect College Sports Act of 2026
Client: UNITED STATES OLYMPIC & PARALYMPIC COMMITTEE · Firm: ALSTON & BIRD LLP
Issues related to Olympic womens and mens collegiate sports. S.4668/H.R.9137, The Protect College Sports Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: REGENTS OF THE UNIVERSITY OF MICHIGAN · Firm: ALSTON & BIRD LLP
Federal health program issues impacting hospitals. Issues related to H.R.1, One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: REGENTS OF THE UNIVERSITY OF MICHIGAN · Firm: ALSTON & BIRD LLP
Federal health program issues impacting hospitals. Issues related to H.R.1, One Big Beautiful Bill Act.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
H.R.1, One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
An act to provide for reconciliation pursuant to title II of H. Con. Res. 14.
Client: BIOMERIEUX, INC. · Firm: ALSTON & BIRD LLP
H.R.1, the One Big Beautiful Bill Act of 2025, provisions relating to Section 899 of US Tax Code. Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). Discussions regarding tariff proposals.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment (per Section 216 of Protecting Access to Medicare Act (PAMA)). H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Advancing research to find a cure for Parkinson's disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE METROHEALTH SYSTEM via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Support for protecting front line multimission hospitals. Sustainability of safety net health systems. Support of telehealth policies, including for audio-only telehealth services. Support for policies to enhance health care workforce programs. Expanding the healthcare workforce. Support for policies to protect access to Medicaid. Protecting the 340B drug discount program. 340b price transparency issues concerning 340B program rebate proposal. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Trauma center certification, funding, and quality; Market saturation of trauma care and detrimental impact patient outcomes.
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
SCHOOL-COMMUNITY HEALTH ALLIANCE OF MICHIGAN via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues regarding grant funding and reimbursement for school-based health care services.
Issues regarding grant funding and reimbursement for school-based health care services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROSPEROUS ROBOTICS via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Advancing legislation and agency action to improve mobility for veterans and other patient groups.
Advancing legislation and agency action to improve mobility for veterans and other patient groups.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PRIMARY CARE ASSOCIATION (INFORMAL COALITION) via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Funding for community health center programs. Medicaid funding.
Funding for community health center programs. Medicaid funding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
OSSIUM HEALTH, INC. via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Advancing contract and other partnership opportunities for Ossium.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
OREGON HEALTH & SCIENCE UNIVERSITY via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues related to academic medicine and research.
Issues related to academic medicine and research.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NATIONAL SOCIETY OF AUTISM PROFESSIONALS via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues related to the reimbursement and credentialing of autism professionals.
Issues related to the reimbursement and credentialing of autism professionals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL FOR MENTAL WELLBEING via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues concerning behavioral health care reimbursement and funding.
Issues concerning behavioral health care reimbursement and funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL BRAIN TUMOR SOCIETY via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2026 · third_quarter · Q3
General legislative and regulatory issues related to Medicare and Medicaid, including 340B, site neutrality payment reform, Medicare Advantage, Telehealth, and medical research indirect costs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
JUDI HEALTH via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Pharmacy Benefit Manager Reform.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HOSPITAL ASSOCIATION OF OREGON via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHTRACKRX via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Medicare and Medicaid laboratory reimbursement issues.
Medicare and Medicaid laboratory reimbursement issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTH CENTER PARTNERS OF SOUTHERN CALIFORNIA via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues related to Teaching Health Center GME, Community Health Center funding, and Telehealth.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DATAVANT INC. via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
CVS HEALTH via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CURIE BIO OPERATIONS, LLC via ALSTON & BIRD LLP
2026 · third_quarter · Q3
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
COLORADO HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B and site neutrality payment reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLARITEV via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues related to healthcare reimbursement; issues related to payment and revenue integrity.
Issues related to healthcare reimbursement; issues related to payment and revenue integrity.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
BIOMERIEUX, INC. via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
AMPUTEE COALITION via ALSTON & BIRD LLP
2026 · third_quarter · Q3
FY2027 Appropriations bills.
FY2027 Appropriations bills.
FY2027 National Defense Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues related to the health insurance industry.
Issues related to the health insurance industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AFLAC, INC. via ALSTON & BIRD LLP
2026 · third_quarter · Q3
Issues relating to excepted benefits and insurance company tax issues.
Issues relating to excepted benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACCENTURE FEDERAL SERVICES LLC via ALSTON & BIRD LLP
2026 · third_quarter · Q3
FY2027 Appropriations bills.
FY2027 Appropriations bills.
FY2027 Appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES OLYMPIC & PARALYMPIC COMMITTEE via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to Olympic womens and mens collegiate sports. S.4668/H.R.9137, The Protect College Sports Act of 2026.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, State, Dept of (DOS), White House Office
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Advancing research to find a cure for Parkinson's disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE METROHEALTH SYSTEM via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
Support for protecting front line multimission hospitals. Sustainability of safety net health systems. Support of telehealth policies, including for audio-only telehealth services. Support for policies to enhance health care workforce programs. Expanding the healthcare workforce. Support for policies to protect access to Medicaid. Protecting the 340B drug discount program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Trauma center certification, funding, and quality; Market saturation of trauma care and detrimental impact patient outcomes.
SCHOOL-COMMUNITY HEALTH ALLIANCE OF MICHIGAN via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues regarding grant funding and reimbursement for school-based health care services.
Issues regarding grant funding and reimbursement for school-based health care services.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
BIOMERIEUX, INC. via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
REGENTS OF THE UNIVERSITY OF MICHIGAN via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Federal health program issues impacting hospitals. Issues related to H.R.1, One Big Beautiful Bill Act.
Federal health program issues impacting hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROSPEROUS ROBOTICS via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Advancing legislation and agency action to improve mobility for veterans and other patient groups.
Advancing legislation and agency action to improve mobility for veterans and other patient groups.
PRIMARY CARE ASSOCIATION (INFORMAL COALITION) via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Funding for community health center programs. Medicaid funding.
Funding for community health center programs. Medicaid funding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
OSSIUM HEALTH, INC. via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Advancing contract and other partnership opportunities for Ossium.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
OREGON HEALTH & SCIENCE UNIVERSITY via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to academic medicine and research.
Issues related to academic medicine and research.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NATIONAL SOCIETY OF AUTISM PROFESSIONALS via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to the reimbursement and credentialing of autism professionals.
Issues related to the reimbursement and credentialing of autism professionals.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
NATIONAL COUNCIL FOR MENTAL WELLBEING via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues concerning behavioral health care reimbursement and funding.
Issues concerning behavioral health care reimbursement and funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL BRAIN TUMOR SOCIETY via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2026 · second_quarter · Q2
General legislative and regulatory issues related to Medicare and Medicaid, including 340B, site neutrality payment reform, Medicare Advantage, Telehealth, and medical research indirect costs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HOSPITAL ASSOCIATION OF OREGON via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHTRACKRX via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Medicare and Medicaid laboratory reimbursement issues.
Medicare and Medicaid laboratory reimbursement issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTH CENTER PARTNERS OF SOUTHERN CALIFORNIA via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to Teaching Health Center GME, Community Health Center funding, and Telehealth.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DATAVANT INC. via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
CVS HEALTH via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
CURIE BIO OPERATIONS, LLC via ALSTON & BIRD LLP
2026 · second_quarter · Q2
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
COLORADO HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B and site neutrality payment reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLARITEV via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to healthcare reimbursement; issues related to payment and revenue integrity.
Issues related to healthcare reimbursement; issues related to payment and revenue integrity.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
AMPUTEE COALITION via ALSTON & BIRD LLP
2026 · second_quarter · Q2
FY2027 Appropriations bills.
FY2027 Appropriations bills.
FY2027 National Defense Authorization Act.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to the health insurance industry.
Issues related to the health insurance industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AGENDIA, INC. via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues related to Medicare coverage.
Issues related to Medicare coverage.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
AFLAC, INC. via ALSTON & BIRD LLP
2026 · second_quarter · Q2
Issues relating to excepted benefits and insurance company tax issues.
Issues relating to excepted benefits.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
ACCENTURE FEDERAL SERVICES LLC via ALSTON & BIRD LLP
2026 · second_quarter · Q2
FY2027 Appropriations bills.
FY2027 Appropriations bills.
FY2027 Appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
NATIONAL SOCIETY OF AUTISM PROFESSIONALS via ALSTON & BIRD LLP
2026 · second_quarter · RR
Issues related to the reimbursement and credentialing of autism professionals.
Issues related to the reimbursement and credentialing of autism professionals.
ACT FOR NIH: ADVANCING CURES TODAY via ALSTON & BIRD LLP
2026 · second_quarter · RR
Issues related to FY2027 appropriations for the National Institutes of Health.
Issues related to FY2027 appropriations for the National Institutes of Health.
SCHOOL-COMMUNITY HEALTH ALLIANCE OF MICHIGAN via ALSTON & BIRD LLP
2026 · second_quarter · RR
Issues regarding grant funding and reimbursement for school-based health care services.
Issues regarding grant funding and reimbursement for school-based health care services.
UNITED STATES OLYMPIC & PARALYMPIC COMMITTEE via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to Olympic womens and mens collegiate sports.
Filing targets: HOUSE OF REPRESENTATIVES, Office of Natl Drug Control Policy (NDCP), SENATE, White House Office
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Advancing research to find a cure for Parkinson's disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
THE METROHEALTH SYSTEM via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Support for protecting front line multimission hospitals. Sustainability of safety net health systems. Support of telehealth policies, including for audio-only telehealth services. Support for policies to enhance health care workforce programs. Expanding the healthcare workforce. Support for policies to protect access to Medicaid. Protecting the 340B drug discount program. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid and protecting multimission hospitals. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Trauma center certification, funding, and quality; Market saturation of trauma care and detrimental impact patient outcomes.
Medicaid State-Directed Payments. 340B Modernization. Funding for Disproportionate Share Hospitals (Medicaid DSH). Support for protecting front line multimission hospitals. Support of telehealth policies, including for audio-only telehealth services. Acute hospital care at home waiver flexibility. In general, support provisions to reform Medicare physician fee schedule payment policies and access to physician services. H.R.879, Medicare Patient Access and Practice Stabilization Act of 2025. Support for policies protecting access to Medicaid. Pub. L. No. 119-21, One Big Beautiful Bill Act, provisions regarding Medicaid provider taxes, state directed payments and other policies. H.R.5371, Continuing Appropriations and Extensions Act, 2026, provisions related to Medicaid DSH, telehealth, Hospital at Home program. H.R.4392, Uterine Fibroid Intervention and Gynecological Health Treatment Act of 2025. Medicare graduate medical education programs/funding; Medicare funding of trauma centers.
REGENTS OF THE UNIVERSITY OF MICHIGAN via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Federal health program issues impacting hospitals. Issues related to H.R.1, One Big Beautiful Bill Act.
Federal health program issues impacting hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROSPEROUS ROBOTICS via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Advancing legislation and agency action to improve mobility for veterans and other patient groups.
Advancing legislation and agency action to improve mobility for veterans and other patient groups.
PRIMARY CARE ASSOCIATION (INFORMAL COALITION) via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Funding for community health center programs. Medicaid funding.
Funding for community health center programs. Medicaid funding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
OSSIUM HEALTH, INC. via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Advancing contract and other partnership opportunities for Ossium.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
OREGON HEALTH & SCIENCE UNIVERSITY via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to academic medicine and research.
Issues related to academic medicine and research.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NATIONAL COUNCIL FOR MENTAL WELLBEING via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues concerning behavioral health care reimbursement and funding.
Issues concerning behavioral health care reimbursement and funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
NATIONAL BRAIN TUMOR SOCIETY via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2026 · first_quarter · Q1
General legislative and regulatory issues related to Medicare and Medicaid, including 340B, site neutrality payment reform, Medicare Advantage, Telehealth, and medical research indirect costs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HOSPITAL ASSOCIATION OF OREGON via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHTRACKRX via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Medicare and Medicaid laboratory reimbursement issues.
Medicare and Medicaid laboratory reimbursement issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTH CENTER PARTNERS OF SOUTHERN CALIFORNIA via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to Teaching Health Center GME, Community Health Center funding, Telehealth and Covid related issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DATAVANT INC. via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE, White House Office
BIOMERIEUX, INC. via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
CVS HEALTH via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
COLORADO HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B and site neutrality payment reforms.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
CLARITEV via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to healthcare reimbursement; issues related to payment and revenue integrity.
Issues related to healthcare reimbursement; issues related to payment and revenue integrity.
Filing targets: Centers For Medicare and Medicaid Services (CMS)
AMPUTEE COALITION via ALSTON & BIRD LLP
2026 · first_quarter · Q1
FY2026 and FY2027 Appropriations bills.
FY2026 and FY2027 Appropriations bills.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
AMERICA'S HEALTH INSURANCE PLANS (AHIP) via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues related to the health insurance industry.
Issues related to the health insurance industry.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ROSS INNOVATIVE EMPLOYMENT SOLUTIONS CORPORATION via ALSTON & BIRD LLP
2026 · first_quarter · 1T
Issues related to federal workforce training programs.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE
NATIONAL ORGANIZATION OF SOCIAL SECURITY CLAIMANTS REPRESENTATIVES (NOSSCR) via ALSTON & BIRD LLP
2026 · first_quarter · 1T
Issues concerning access to medical records for purposes of SSDI claims.
Issues concerning access to medical records for purposes of SSDI claims.
AFLAC, INC. via ALSTON & BIRD LLP
2026 · first_quarter · Q1
Issues relating to excepted benefits.
Issues relating to excepted benefits and insurance company tax issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
UNITED STATES OLYMPIC & PARALYMPIC COMMITTEE via ALSTON & BIRD LLP
2026 · first_quarter · RR
Issues relating to the Ted Stevens Olympic & Amateur Sports Act of 1978; issues relating to anti-doping; issues related to visas, immigration; issues related to commemorative coins.
Issues relating to the Ted Stevens Olympic & Amateur Sports Act of 1978; issues relating to anti-doping; issues related to visas, immigration; issues related to commemorative coins.
Issues relating to the Ted Stevens Olympic & Amateur Sports Act of 1978; issues relating to anti-doping; issues related to visas, immigration; issues related to commemorative coins.
AMPUTEE COALITION via ALSTON & BIRD LLP
2026 · first_quarter · RR
FY2026 and FY2027 Appropriations bills.
FY2026 and FY2027 Appropriations bills.
DATAVANT INC. via ALSTON & BIRD LLP
2025 · first_quarter · 1A
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
THE MICHAEL J. FOX FOUNDATION FOR PARKINSON'S RESEARCH via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Advancing research to find a cure for Parkinson's disease.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
ROSS INNOVATIVE EMPLOYMENT SOLUTIONS CORPORATION via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues related to federal workforce training programs.
Filing targets: Agriculture, Dept of (USDA), HOUSE OF REPRESENTATIVES, Labor, Dept of (DOL), SENATE, Small Business Administration (SBA)
REGENTS OF THE UNIVERSITY OF MICHIGAN via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Federal health program issues impacting hospitals. Issues related to H.R.1, One Big Beautiful Bill Act.
Federal health program issues impacting hospitals.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
PROSPEROUS ROBOTICS via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Advancing legislation and agency action to improve mobility for veterans and other patient groups.
Advancing legislation and agency action to improve mobility for veterans and other patient groups.
PRIMARY CARE ASSOCIATION (INFORMAL COALITION) via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Funding for community health center programs. Medicaid funding.
Funding for community health center programs. Medicaid funding.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Labor, Dept of (DOL), SENATE
OSSIUM HEALTH, INC. via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Advancing contract and other partnership opportunities for Ossium.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), SENATE
OREGON HEALTH & SCIENCE UNIVERSITY via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues related to academic medicine and research.
Issues related to academic medicine and research.
Issues related to academic medicine and research.
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), SENATE
NATIONAL ORGANIZATION OF SOCIAL SECURITY CLAIMANTS REPRESENTATIVES (NOSSCR) via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues concerning access to medical records for purposes of SSDI claims.
Issues concerning access to medical records for purposes of SSDI claims.
NATIONAL COUNCIL FOR MENTAL WELLBEING via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues concerning behavioral health care reimbursement and funding.
Issues concerning behavioral health care reimbursement and funding.
Filing targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), Office of Management & Budget (OMB), Office of Natl Drug Control Policy (NDCP), SENATE
NATIONAL BRAIN TUMOR SOCIETY via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Lobbying related to support and introduction of legislation to promote awareness of, research on and treatment of brain tumors.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
MASSACHUSETTS HOSPITAL ASSOCIATION via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
General legislative and regulatory issues related to Medicare and Medicaid, including 340B, site neutrality payment reform, Medicare Advantage, Telehealth, and medical research indirect costs.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
HOSPITAL ASSOCIATION OF OREGON via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Hospital issues, including Medicare and Medicaid-related hospital issues, including 340B, site neutrality and Medicare Advantage.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
HEALTHTRACKRX via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Medicare and Medicaid laboratory reimbursement issues.
Medicare and Medicaid laboratory reimbursement issues.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
HEALTH CENTER PARTNERS OF SOUTHERN CALIFORNIA via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues related to Teaching Health Center GME, Community Health Center funding, Telehealth and Covid related issues.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
DATAVANT INC. via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Information sharing across the health care ecosystem.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
DANA-FARBER CANCER INSTITUTE, INC. via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Federal research funding and general health care issues.
Medicare hospital reimbursement.
Filing targets: HOUSE OF REPRESENTATIVES, Natl Institutes of Health (NIH), Office of Management & Budget (OMB), SENATE
CVS HEALTH via ALSTON & BIRD LLP
2025 · fourth_quarter · Q4
Issues related to Pub. L. No. 119-21, One Big Beautiful Bill Act, PBM reform and drug pricing.
Filing targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, SENATE
FY2027 Appropriations bills; H.R.9102/S.5316, Biotech Investment National Security Act of 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Support for H.R.3164/S.2426, Ensuring Community Access to Pharmacist Services Act.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics.
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act. Reforming technical certification of in vitro diagnostic tests.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
FY2027 Appropriations bills; H.R. 9102, Biotech Investment National Security Act of 2026.
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues regarding prevention of antimicrobial resistance and incentives for development of new antibiotics. Reform of Medicare clinical laboratory payment per Section 216 of Protecting Access to Medicare Act, Pub. L. No. 113-93, and H.R.5269/S.2761, The Reforming and Enhancing Sustainable Updates to Laboratory Testing Services (RESULTS) Act.
Filing targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
Issues relating to the Ted Stevens Olympic & Amateur Sports Act of 1978; issues relating to anti-doping; issues related to visas, immigration; issues related to commemorative coins.